Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Statements of Changes in Shareholders??? Equity

v3.22.1
Consolidated Statements of Changes in Shareholders’ Equity - USD ($)
$ in Thousands
Ordinary shares
Treasury shares
Pre-funded warrants
Additional paid-in capital
Accumulated deficit
Total
Balance at Dec. 31, 2019 $ 3,318 $ (41) $ 44,820 $ (44,806) $ 3,291
Balance (in Shares) at Dec. 31, 2019 15,029,470 (5,434)      
Issuance of ordinary shares, net [1] $ 1,203 4,644 5,847
Issuance of ordinary shares, net (in Shares) [1] 5,175,000      
Options exercised $ 3 8 11
Options exercised (in Shares) 13,750      
Share-based compensation related to options granted 229 229
Cancelation of par value $ (4,524) 4,524
Cancelation of par value (in Shares)          
Loss for the year (3,730) (3,730)
Balance at Dec. 31, 2020 $ (41) 54,225 (48,536) 5,648
Balance (in Shares) at Dec. 31, 2020 20,218,220 (5,434)      
Issuance of ordinary shares, net [2] 14,586 14,586
Issuance of ordinary shares, net (in Shares) [2] 11,485,697      
Issuance of ordinary shares public offering in December 2021, net [3] 12,400 12,400
Issuance of ordinary shares public offering in December 2021, net (in Shares) [3] 3,892,152      
Issuance of pre-funded warrants 3,566 3,566
Issuance of pre-funded warrants (in Shares)   1,034,000      
Options exercised 337 337
Options exercised (in Shares) 189,700      
Share-based compensation related to options granted 316 316
Cancelation of treasury shares $ 41 (41)
Cancelation of treasury shares (in Shares) (5,434) 5,434      
Loss for the year (9,895) (9,895)
Balance at Dec. 31, 2021 $ 85,389 $ (58,431) $ 26,958
Balance (in Shares) at Dec. 31, 2021 35,780,335 1,034,000      
[1] Net of issuance cost of approximately $219
[2] Net of issuance cost of approximately $414
[3] Net of issuance cost of approximately $1,028